Title
a. Approve and authorize the Director of Health Services or their designee to execute a non-standard Agreement with Dynex Technologies, to provide service for a Dynex DS2 instrument for the term upon execution to August 31, 2026, and a total Agreement amount not to exceed $31,779; and
b. Approve non-standard risk provisions in the Agreement as recommended by the Director of Health Services; and
c. Approve and authorize the Director of Health Services or their designee to sign up to three future amendments to this Agreement where the amendments do not significantly change the scope of work, do not exceed 10% ($3,179) of the original contract amount; total not to exceed maximum of $34,958.
Report
RECOMMENDATION:
It is recommended that the Board of Supervisors:
a. Approve and authorize the Director of Health Services or their designee to execute a non-standard Agreement with Dynex Technologies, to provide service for a Dynex DS2 instrument for the term upon execution to August 31, 2026, and a total Agreement amount not to exceed $31,779; and
b. Approve non-standard risk provisions in the Agreement as recommended by the Director of Health Services; and
c. Approve and authorize the Director of Health Services or their designee to sign up to three future amendments to this Agreement where the amendments do not significantly change the scope of work, do not exceed 10% ($3,179) of the original contract amount; total not to exceed maximum of $34,958.
SUMMARY DISCUSSION:
The Health Department's Public Health Laboratory (PHL) is responsible for providing testing services to identify microorganisms that cause disease including bacteria, fungi, viruses, and parasites. The PHL provides testing with associated whole genome sequencing for communicable disease surveillance purposes, surge events and other public health emergencies. The PHL also serves as a reference laboratory for local hospitals and health care agencies.
The PHL seeks approval to purchase preventa...
Click here for full text